| Application no. and date | 17710874.3 (espacenet) (Federated) (European Patent Register), 20170314 | | Patent/reg. no. and date | DK/EP 3430141, 20201230 | | Publication date | 20190123 | | Priority no. and date | EP 16160149, 20160314 | | EP pub. no. and date |
EP 3430141 20190123 | | Effective date | | | Applicant/owner | F. Hoffmann-La Roche AG, Grenzacherstrasse 124
4070 Basel, CH | | Applicant ref. no. | P75795DK01 | | Inventor | JAVANBAKHT, Hassan, c/o F. Hoffmann-La Roche AG
Grenzacherstrasse 124
4070 Basel, CH,
PEDERSEN, Lykke, c/o Roche Innovation Center Copenhagen A/S
Fremtidsvej 3, 2970 Hørsholm, DK,
JACKEROTT, Malene, c/o Roche Innovation Center Copenhagen A/S
Fremtidsvej 3, 2970 Hørsholm, DK,
OTTOSEN, Søren, c/o Roche Innovation Center Copenhagen A/S
Fremtidsvej 3, 2970 Hørsholm, DK,
LUANGSAY, Souphalone, c/o F. Hoffmann-La Roche AG
Grenzacherstrasse 124
4070 Basel, CH | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup | | Opponent | | | IPC Class | A61K 31/712 (2006.01) , A61K 31/7125 (2006.01) , A61K 47/50 (2017.01) , A61P 31/00 (2006.01) , A61P 33/02 (2006.01) , A61P 37/04 (2006.01) , C07H 21/00 (2006.01) , C12N 15/113 (2010.01) | | Title | Oligonukleotider til reduktion af PD-L1-ekspression | | Int. application no. | EP2017055925 | | Int. publication no. | WO2017157899 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
